Thursday, September 1, 2011

Pathway Medical Acquired By Bayer Healthcare

Kirkland, Washington-based Pathway Medical Technologies, a developer of products for treating Peripheral Arterial Disease (PAD), has been acquired by Bayer Healthcare. Financial terms of the buy were not disclosed. Bayer said the acuqisitoin would strengthen its MEDRAD Interventional business. Pathway Medical had been venture backed by ABN AMRO Ventures, Accelerated Technologies, Forbion Capital Partners, Giza Venture Capital,HLM Venture Partners, Latterell Venture Partners, Oxford Bioscience Partners, and WRF Capital. The firm had raised north of $112M for its products.